Have a personal or library account? Click to login
Research Article. The Prevalence of Dysphotopsia in Patients with Recent Cataract Surgery Cover

Research Article. The Prevalence of Dysphotopsia in Patients with Recent Cataract Surgery

Open Access
|Apr 2017

Abstract

Pseudophakic dysphotopsia are becoming increasingly important as unwanted side effect after cataract surgery. Objective: The purpose of this study is to compare the photic symptoms experienced by patients after cataract surgery. Material and method: This is a prospective study that included 105 eyes from 99 patients, which underwent uncomplicated phacoemulsification and IOL implantation, between June 2015 and June 2016, performed at Ophthalmology Clinic Tg Mureș. Patients without visually consequential ocular co-morbidity completed a questionnaire, designed to assess subjectively perceived visual functioning and identify symptoms of dysphotopsia. Results: From the total number of patient, hydrophobic lenses were implanted in 95 patients and 10 patients received hydrophilic lenses. Photic effects were reported in 18% of treated eyes. Although the percentage of dysphotopsia is higher in the hydrophobic lenses category, there was no significant statistical difference between the two categories. Conclusion: The incidence and significance should not be overlooked, thus visual acuity is not enough for evaluating postoperative visual function.

DOI: https://doi.org/10.1515/amma-2017-0002 | Journal eISSN: 2668-7763 | Journal ISSN: 2668-7755
Language: English
Page range: 15 - 18
Submitted on: Aug 17, 2016
Accepted on: Dec 27, 2016
Published on: Apr 20, 2017
Published by: University of Medicine, Pharmacy, Science and Technology of Targu Mures
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2017 Andreea Dana Fişuş, Zoltán Madaras, Karin Ursula Horváth, published by University of Medicine, Pharmacy, Science and Technology of Targu Mures
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.